Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension

Free Subscription Articles published in Am J Respir Crit Care Med Retrieve available abstracts of 122 articles: HTML format

Single Articles

November 2025
1. SAVALE L, d'Humieres T, Boucly A, Habibi A, et al
   Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.
   Am J Respir Crit Care Med. 2025;211:2096-2104.
   PubMed     Abstract available
   
   
   October 2025
2. KOHLI A, DuBrock HM, Boland JM, Kennedy CC, et al
   A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202505-1140.
   PubMed    
   
   
   
3. GLADWIN MT, Kato GJ, Machado RF
   10-Year Longitudinal Study Clarifies Impact of Hemolysis and Pulmonary Hypertension on Patients with Sickle Cell Anemia.
   Am J Respir Crit Care Med. 2025 Oct 10. doi: 10.1164/rccm.202509-2289.
   PubMed    
   
   
   
4. YOGESWARAN A, Hassoun PM, Saleh K, Funderich M, et al
   Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.
   Am J Respir Crit Care Med. 2025;211:1855-1866.
   PubMed     Abstract available
   
   
   September 2025
5. SHLOBIN OA, Piccari L
   A 10,000-Foot View at Survival and Treatment with PDE5 Inhibitors in Interstitial Lung Disease Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2025 Sep 8. doi: 10.1164/rccm.202508-1980.
   PubMed    
   
   
   
6. REDDY YNV, Asokan AK, Frantz RP, Hemnes A, et al
   Metabolomic Evidence of Biological Overlap with Heart Failure with Preserved Ejection Fraction in a Subset of Pulmonary Arterial Hypertension.
   Am J Respir Crit Care Med. 2025;211:1701-1713.
   PubMed     Abstract available
   
   
   August 2025
7. DE BIE E, Correa-Jaque P, Jones R, Bogaard HJ, et al
   Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging Outcomes.
   Am J Respir Crit Care Med. 2025 Aug 11. doi: 10.1164/rccm.202412-2393.
   PubMed     Abstract available
   
   
   June 2025
8. NAIDU SR, Desai AA
   A Peek into Pulmonary Hypertension Through the Plasma Proteome.
   Am J Respir Crit Care Med. 2025 Jun 26. doi: 10.1164/rccm.202505-1063.
   PubMed    
   
   
   
9. CASSADY SJ, Gladwin MT
   The Mirage of Individualized Therapy in the United States: Barriers in Pulmonary Hypertension Due to Sickle Cell Disease & Sarcoidosis.
   Am J Respir Crit Care Med. 2025 Jun 26. doi: 10.1164/rccm.202411-2126.
   PubMed    
   
   
   
10. SIMOES DE JESUS D, Buffonge S, Abis G, Buccafusca R, et al
    Zinc-mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025.
    PubMed     Abstract available
    
    
    
11. LIU S, Shan X, Sun Y, Chen H, et al
    Deficient FANCL Predisposes Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025.
    PubMed     Abstract available
    
    
    
12. ROTHMAN AMK, Villar SS, Middleton J, Roussakis AA, et al
    Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study.
    Am J Respir Crit Care Med. 2025;211:1018-1027.
    PubMed     Abstract available
    
    
    
13. MONTANI D, McLaughlin VV, Gibbs JSR, Gomberg-Maitland M, et al
    Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR).
    Am J Respir Crit Care Med. 2025;211:1028-1037.
    PubMed     Abstract available
    
    
    
14. NATHAN SD, Kim HC, King CS, Aryal S, et al
    Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant.
    Am J Respir Crit Care Med. 2025;211:984-991.
    PubMed     Abstract available
    
    
    May 2025
15. HARBAUM L, Klose H, Wilkins MR
    From Blood to Vessel: Lipid Ratios in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025.
    PubMed    
    
    
    
16. BOUCLY A, Song S, Keles M, Wang D, et al
    Clustering Pulmonary Hypertension Patients Using the Plasma Proteome.
    Am J Respir Crit Care Med. 2025.
    PubMed     Abstract available
    
    
    
17. BORDAG N, Nagy BM, Zugner E, Ludwig H, et al
    Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025.
    PubMed     Abstract available
    
    
    April 2025
18. SUNTHARALINGAM J, Toshner MR, Blacker K, Howard LS, et al
    How Can We Ensure Accessible and High-Quality Specialist Care for Pulmonary Hypertension Patients?
    Am J Respir Crit Care Med. 2025.
    PubMed    
    
    
    
19. LEARY PJ, Le RJ, Panjabi S, Hartney J, et al
    Location of Care Delivery for Pulmonary Arterial Hypertension in the United States.
    Am J Respir Crit Care Med. 2025;211:619-627.
    PubMed     Abstract available
    
    
    February 2025
20. GILLMEYER KR, Johnson SW
    Pulmonary Hypertension Care Delivery in the U.S.: Is It Time to Get with the Guidelines?
    Am J Respir Crit Care Med. 2025 Feb 25. doi: 10.1164/rccm.202501-0107.
    PubMed    
    
    
    November 2024
21. HAYES D JR, Jennerich AL, Coleman RD, Abston E, et al
    Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy. An Official American Thoracic Society Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2024 Nov 12. doi: 10.1164/rccm.202410-1901.
    PubMed     Abstract available
    
    
    October 2024
22. KREMER N, Schaefer S, Yogeswaran A, Rako Z, et al
    Exercise Limitation in Pulmonary Hypertension - Physiological Insights into the Six-Minute Walk Test.
    Am J Respir Crit Care Med. 2024 Oct 15. doi: 10.1164/rccm.202407-1397.
    PubMed    
    
    
    
23. ZEDER K
    Beyond the Lung: Viewing Treatment Response through the Liver in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;210:976-978.
    PubMed    
    
    
    September 2024
24. KOVACS G, Moutchia J, Zeder K, Maron BA, et al
    Clinical Response to Pulmonary Arterial Hypertension Treatment Does Not Depend on Pulmonary Arterial Wedge Pressure: A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials.
    Am J Respir Crit Care Med. 2024;210:844-847.
    PubMed    
    
    
    
25. XU Z, Li Q, Zhang C, Wang Q, et al
    Viscosity-Corrected Pulmonary Vascular Resistance Index in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;210:831-834.
    PubMed    
    
    
    
26. RAYNER SG, Tedford RJ, Leary PJ, Mak S, et al
    "This Patient Needs a Doctor, Not a Guideline!" The Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement.
    Am J Respir Crit Care Med. 2024;210:712-714.
    PubMed    
    
    
    
27. SAHAY S, Chakinala MM, Kim NH, Preston IR, et al
    Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective.
    Am J Respir Crit Care Med. 2024;210:581-592.
    PubMed     Abstract available
    
    
    August 2024
28. BADAGLIACCA R, Ghio S, D'Alto M, Ameri P, et al
    Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study.
    Am J Respir Crit Care Med. 2024;210:362-365.
    PubMed    
    
    
    
29. TUDER RM, Gandjeva A, Williams S, Kumar S, et al
    Digital Spatial Profiling Identifies Distinct Molecular Signatures of Vascular Lesions in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;210:329-342.
    PubMed     Abstract available
    
    
    June 2024
30. TOSHNER M
    Searching for an Elusive Phantom - Targeting Oestrogen in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2024 Jun 26. doi: 10.1164/rccm.202405-1029.
    PubMed    
    
    
    
31. LEMAY SE, Grobs Y, Romanet C, Martineau S, et al
    Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:1376-1391.
    PubMed     Abstract available
    
    
    May 2024
32. SCOTT JV, Moutchia J, McClelland RL, Al-Naamani N, et al
    Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2024 May 31. doi: 10.1164/rccm.202311-2196.
    PubMed     Abstract available
    
    
    
33. KAWUT SM, Feng R, Ellenberg SS, Zamanian R, et al
    Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Am J Respir Crit Care Med. 2024 May 15. doi: 10.1164/rccm.202402-0371.
    PubMed     Abstract available
    
    
    
34. OLDROYD SH, Manek G, Bhardwaj A, Zamanian RT, et al
    Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:1189-1195.
    PubMed     Abstract available
    
    
    
35. VILLAMOR E, Gonzalez-Luis GE
    Pulmonary Hypertension and Lung Damage Associated with Prolonged Exposure to Patent Ductus Arteriosus in Very Preterm Infants.
    Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0694.
    PubMed    
    
    
    April 2024
36. BJORKMAN KR, Miles KG, Bellew LE, Schneider KA, et al
    Patent Ductus Arteriosus and Lung MRI Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2024 Apr 3. doi: 10.1164/rccm.202310-1733.
    PubMed     Abstract available
    
    
    March 2024
37. EICHSTAEDT CA
    Genetically Identifying the "Thrombo-embolic" in CTEPH.
    Am J Respir Crit Care Med. 2024 Mar 27. doi: 10.1164/rccm.202402-0471.
    PubMed    
    
    
    
38. HARDER E, Abtin F, Nardelli P, Brownstein A, et al
    Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning.
    Am J Respir Crit Care Med. 2024 Mar 19. doi: 10.1164/rccm.202312-2343.
    PubMed    
    
    
    
39. JAIN A, Epelbaum O
    Synchronous Pulmonary Arterial and Pulmonary Venous Thrombosis in Pancreatic Cancer.
    Am J Respir Crit Care Med. 2024;209:751-752.
    PubMed    
    
    
    
40. LILEY J, Newnham M, Bleda M, Bunclark K, et al
    Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.
    Am J Respir Crit Care Med. 2024 Mar 12. doi: 10.1164/rccm.202307-1236.
    PubMed     Abstract available
    
    
    February 2024
41. KUDRYASHOVA TV, Jiang L, Goncharova EA
    What Is All of the Hype About? Hypusine Signaling as a Driver of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2024 Feb 27. doi: 10.1164/rccm.202401-0195.
    PubMed    
    
    
    
42. NAEIJE R, Tonelli AR
    Pulmonary Artery Wedge Pressure in the Diagnosis of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:242-244.
    PubMed    
    
    
    
43. HARDER EM, Divo MJ, Washko GR, Leopold JA, et al
    Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:316-324.
    PubMed     Abstract available
    
    
    January 2024
44. RAJAGOPAL S, Yu YR
    Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:131-133.
    PubMed    
    
    
    
45. FERRIAN S, Cao A, McCaffrey EF, Saito T, et al
    Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.
    Am J Respir Crit Care Med. 2024;209:206-218.
    PubMed     Abstract available
    
    
    December 2023
46. YASUMA T, Fujimoto H, D'Alessandro-Gabazza CN, Gabazza EC, et al
    Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;208:1248.
    PubMed    
    
    
    
47. WEATHERALD J, Moutchia J, Al-Naamani N, McClelland RL, et al
    Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
    Am J Respir Crit Care Med. 2023;208:1231-1234.
    PubMed    
    
    
    September 2023
48. GUO M, Wikenheiser-Brokamp KA, Kitzmiller JA, Jiang C, et al
    Single Cell Multiomics Identifies Cells and Genetic Networks Underlying Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2023;208:709-725.
    PubMed     Abstract available
    
    
    
49. NORLANDER AE, Abney M, Cephus JY, Roe CE, et al
    Prostaglandin I(2) Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;208:737-739.
    PubMed    
    
    
    
50. FARHA S, Aldred MA
    Regulating the Regulators: Epigenetic Modulation of Regulatory T-Cells in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Sep 8. doi: 10.1164/rccm.202308-1456.
    PubMed    
    
    
    August 2023
51. ROCHESTER CL, Alison JA, Carlin B, Jenkins AR, et al
    Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2023;208:e7-e26.
    PubMed     Abstract available
    
    
    
52. HAN MK
    From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue.
    Am J Respir Crit Care Med. 2023;208:339-340.
    PubMed    
    
    
    
53. BRITTAIN EL, Tedford RJ, Maron BA
    Reply to: Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202307-1180.
    PubMed    
    
    
    
54. WU Y, Su X, Wang J, Zhang H, et al
    Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202306-1076.
    PubMed    
    
    
    
55. FORBES LM, Bull TM, Lahm T, Lawley JS, et al
    Right Ventricular Response to Acute Hypoxia among Healthy Humans.
    Am J Respir Crit Care Med. 2023;208:333-336.
    PubMed    
    
    
    July 2023
56. JOHNSON S, Sommer N, Cox-Flaherty K, Weissmann N, et al
    Pulmonary Hypertension: A Contemporary Review.
    Am J Respir Crit Care Med. 2023 Jul 14. doi: 10.1164/rccm.202302-0327.
    PubMed     Abstract available
    
    
    
57. LEIVA O, Garcia BD, Hobbs G
    Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons.
    Am J Respir Crit Care Med. 2023 Jul 10. doi: 10.1164/rccm.202306-1001.
    PubMed    
    
    
    June 2023
58. WEATHERALD J, Zanini U, Humbert M
    Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Jun 22. doi: 10.1164/rccm.202306-0990.
    PubMed    
    
    
    
59. MARON BA
    Introducing the Pulmonary Hypertension Thematic Series.
    Am J Respir Crit Care Med. 2023 Jun 21. doi: 10.1164/rccm.202306-1005.
    PubMed    
    
    
    
60. SONNTAG E, Akgun KM, Bag R, Rosensweig EB, et al
    Access to Medically Necessary Reproductive Care for Individuals with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202302-0230.
    PubMed    
    
    
    
61. MONTANI D, Thore P, Mignard X, Jais X, et al
    Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
    Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202210-1941.
    PubMed     Abstract available
    
    
    
62. WANG RS, Huang S, Waldo SW, Hess E, et al
    Elevated Pulmonary Arterial Compliance Is Associated with Survival in Pulmonary Hypertension: Results from a Novel Network Medicine Analysis.
    Am J Respir Crit Care Med. 2023 Jun 5. doi: 10.1164/rccm.202211-2097.
    PubMed     Abstract available
    
    
    
63. YANAGIHARA T, Tsubouchi K, Zhou Q, Chong M, et al
    Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
    Am J Respir Crit Care Med. 2023;207:1498-1514.
    PubMed     Abstract available
    
    
    May 2023
64. QUARCK R, Bogaard HJ, Delcroix M
    The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?
    Am J Respir Crit Care Med. 2023;207:1266-1268.
    PubMed    
    
    
    
65. NATHAN SD
    Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease.
    Am J Respir Crit Care Med. 2023 May 9. doi: 10.1164/rccm.202212-2342.
    PubMed     Abstract available
    
    
    
66. BRUSATORI S, Zinnato C, Busana M, Romitti F, et al
    High- versus Low-Flow Extracorporeal Respiratory Support in Experimental Hypoxemic Acute Lung Injury.
    Am J Respir Crit Care Med. 2023;207:1183-1193.
    PubMed     Abstract available
    
    
    April 2023
67. ULRICH S
    A Further Step Toward Meaningful Trial Outcomes for Patients with Pulmonary Arterial Hypertension: Minimal Important Difference in 6-minute-walk Distance.
    Am J Respir Crit Care Med. 2023;207:972-974.
    PubMed    
    
    
    
68. VANDERPOOL RR, Insel M, Kubba S, Rischard FP, et al
    The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling.
    Am J Respir Crit Care Med. 2023;207:1100-1102.
    PubMed    
    
    
    
69. MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
    Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;207:1070-1079.
    PubMed     Abstract available
    
    
    
70. CORNFIELD DN, Nogee LM
    Rare to "Ubiquitinous": Alveolar Capillary Dysplasia, FOXF1, and a Sly Approach to Angiogenesis.
    Am J Respir Crit Care Med. 2023;207:969-971.
    PubMed    
    
    
    
71. PRADHAN A, Che L, Ustiyan V, Reza AA, et al
    Novel FOXF1-Stabilizing Compound TanFe Stimulates Lung Angiogenesis in Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2023;207:1042-1054.
    PubMed     Abstract available
    
    
    
72. MCNAMARA PJ, Lakshminrusimha S
    Maldevelopment of the Immature Pulmonary Vasculature and Prolonged Patency of the Ductus Arteriosus: Association or Cause?
    Am J Respir Crit Care Med. 2023;207:814-816.
    PubMed    
    
    
    March 2023
73. LIN S, Frank DB
    SOX17 at the Intersection of Sex, Transcription, and Metabolism in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Mar 16. doi: 10.1164/rccm.202302-0284.
    PubMed    
    
    
    
74. OLIVEIRA SD
    Cardiopulmonary Pathogenic Networks: Unveiling the Gut-Lung Microbiome Axis in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;207:655-657.
    PubMed    
    
    
    
75. MOUTSOGLOU DM, Tatah J, Prisco SZ, Prins KW, et al
    Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.
    Am J Respir Crit Care Med. 2023;207:740-756.
    PubMed     Abstract available
    
    
    
76. SANGAM S, Sun X, Schwantes-An TH, Yegambaram M, et al
    SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics.
    Am J Respir Crit Care Med. 2023 Mar 13. doi: 10.1164/rccm.202203-0450.
    PubMed     Abstract available
    
    
    
77. 
    Erratum: Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure.
    Am J Respir Crit Care Med. 2023;207:636.
    PubMed    
    
    
    February 2023
78. VISWANATHAN G, Kirshner HF, Nazo N, Ali S, et al
    Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Feb 21. doi: 10.1164/rccm.202203-0441.
    PubMed     Abstract available
    
    
    
79. XANTHOULI P
    Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
    Am J Respir Crit Care Med. 2023;207:238-240.
    PubMed    
    
    
    
80. GOLDBERG HJ
    Comparing the Incomparable: Identifying Common Themes Across a Diverse Landscape to Address Equity in Lung Allocation.
    Am J Respir Crit Care Med. 2023;207:236-238.
    PubMed    
    
    
    
81. HASSAN HJ, Naranjo M, Ayoub N, Housten T, et al
    Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry.
    Am J Respir Crit Care Med. 2023;207:312-322.
    PubMed     Abstract available
    
    
    
82. KOLAITIS NA, Chen H, Calabrese DR, Kumar K, et al
    The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision.
    Am J Respir Crit Care Med. 2023;207:300-311.
    PubMed     Abstract available
    
    
    January 2023
83. WANG ZH, Zhou Q
    Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
    Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202211-2134.
    PubMed    
    
    
    
84. JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
    Reply to: Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
    Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202212-2214.
    PubMed    
    
    
    
85. RAFFAY TM, Jensen EA
    Can Intermittent Hypoxemia Help Detect Pulmonary Hypertension in High-Risk Preemies?
    Am J Respir Crit Care Med. 2023 Jan 11. doi: 10.1164/rccm.202212-2290.
    PubMed    
    
    
    December 2022
86. DOUSCHAN P, Avian A, Foris V, Sassmann T, et al
    Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure.
    Am J Respir Crit Care Med. 2022;206:1418-1423.
    PubMed    
    
    
    November 2022
87. GENTLE SJ, Travers CP, Nakhmani A, Indic P, et al
    Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants.
    Am J Respir Crit Care Med. 2022 Nov 30. doi: 10.1164/rccm.202203-0580.
    PubMed     Abstract available
    
    
    
88. GENTLE SJ, Travers CP, Clark M, Carlo WA, et al
    Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Nov 15. doi: 10.1164/rccm.202203-0570.
    PubMed     Abstract available
    
    
    October 2022
89. MONTANI D, Weatherald J, Humbert M, Sitbon O, et al
    Reply to: Effect of Covid-19 Infection in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Oct 17. doi: 10.1164/rccm.202210-1889.
    PubMed    
    
    
    
90. JHA AK
    Effect of Covid-19 Infection in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Oct 17. doi: 10.1164/rccm.202209-1790.
    PubMed    
    
    
    
91. TAYLOR S, Isobe S, Cao A, Contrepois K, et al
    Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:1019-1034.
    PubMed     Abstract available
    
    
    September 2022
92. AL-QAZAZI R, Lima PDA, Prisco SZ, Potus F, et al
    Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:608-624.
    PubMed     Abstract available
    
    
    
93. BELHAJ A, Dewachter L, Hupkens E, Remmelink M, et al
    Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs.
    Am J Respir Crit Care Med. 2022;206:584-595.
    PubMed     Abstract available
    
    
    August 2022
94. COTTIN V, Selman M, Inoue Y, Wong AW, et al
    Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
    Am J Respir Crit Care Med. 2022;206:e7-e41.
    PubMed     Abstract available
    
    
    
95. 
    Erratum: Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Am J Respir Crit Care Med. 2022;206:362-363.
    PubMed    
    
    
    July 2022
96. YUAN P, Li J, Liu J, Liu H, et al
    Cognitive Dysfunction in Patients with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jul 29. doi: 10.1164/rccm.202204-0726.
    PubMed    
    
    
    
97. WERTHEIM BM
    New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:12-13.
    PubMed    
    
    
    
98. FRECH TM, Austin ED
    Is It Still "Idiopathic"? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:8-10.
    PubMed    
    
    
    
99. JONES RJ, De Bie EMDD, Groves E, Zalewska KI, et al
    Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:81-93.
    PubMed     Abstract available
    
    
    June 2022
100. HERSI K, Elinoff JM
     Pulmonary Hypertension due to Interstitial Lung Disease: A New iNKlinig into Disease Pathobiology.
     Am J Respir Crit Care Med. 2022 Jun 30. doi: 10.1164/rccm.202206-1186.
     PubMed    
     
     
     
101. JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
     Impairment of the NKT-STAT1-CXCL9-axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Due to Lung Fibrosis.
     Am J Respir Crit Care Med. 2022 Jun 28. doi: 10.1164/rccm.202201-0142.
     PubMed     Abstract available
     
     
     
102. ABMAN SH, Mullen MP
     Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202206-1180.
     PubMed    
     
     
     
103. OKAZAKI A, Kinuya K, Fujimoto M
     Diffuse Decreased Blood Flow in the Right Lung: Mitral Regurgitation-Induced Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202110-2339.
     PubMed    
     
     
     
104. SOBRANO FAIS R, Lahm T
     Misbehaving Guests in the Right Ventricle: Macrophage NLRP3 Activation in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2022 Jun 15. doi: 10.1164/rccm.202205-0977.
     PubMed    
     
     
     
105. SIMPSON CE, Hassoun PM
     Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2022;205:1377-1379.
     PubMed    
     
     
     
106. HARBAUM L, Rhodes CJ, Wharton J, Lawrie A, et al
     Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2022;205:1449-1460.
     PubMed     Abstract available
     
     
     
107. PRZEBINDA AS, El Haj Chehade A, Farooqui SM, Youness HA, et al
     Assessment of Pulmonary Vascular Disease: Pulmonary Vascular Resistance, Exercise Hemodynamics, and Ventriculovascular Coupling.
     Am J Respir Crit Care Med. 2022;205:1349.
     PubMed    
     
     
     
108. PROVENCHER S, Potus F, Blais-Lecours P, Bernard S, et al
     BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial.
     Am J Respir Crit Care Med. 2022;205:1357-1360.
     PubMed    
     
     
     May 2022
109. LAPATRA T, Baird GL, Goodman R, Pinder D, et al
     Reply to: Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
     Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202205-0867.
     PubMed    
     
     
     
110. HELGESON SA, Burger CD, Moss JE, Zeiger TK, et al
     Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
     Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202204-0762.
     PubMed    
     
     
     
111. ALBA GA
     Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19.
     Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202205-0884.
     PubMed    
     
     
     
112. CONSTANTINE A, Dimopoulos K, Haworth SG, Muthurangu V, et al
     Twenty-year experience and outcomes in a National Pediatric Pulmonary Hypertension Service.
     Am J Respir Crit Care Med. 2022 May 17. doi: 10.1164/rccm.202110-2428.
     PubMed     Abstract available
     
     
     
113. JIN Q, Guan L, Pan W, Zhang X, et al
     Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.
     Am J Respir Crit Care Med. 2022;205:1250-1251.
     PubMed    
     
     
     
114. MONTANI D, Certain MC, Weatherald J, Jais X, et al
     COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
     Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202112-2761.
     PubMed     Abstract available
     
     
     
115. RAO R, Chan SY
     A dUTY to Protect: Addressing "Y" We See Sex Differences in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202204-0653.
     PubMed    
     
     
     
116. CUNNINGHAM CM, Li M, Ruffenach G, Doshi M, et al
     Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines.
     Am J Respir Crit Care Med. 2022 May 3. doi: 10.1164/rccm.202110-2309.
     PubMed     Abstract available
     
     
     
117. SINGH N, Ventetuolo CE
     Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
     Am J Respir Crit Care Med. 2022;205:988-990.
     PubMed    
     
     
     
118. RHODES CJ, Wharton J, Swietlik EM, Harbaum L, et al
     Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2022;205:1102-1111.
     PubMed     Abstract available
     
     
     April 2022
119. TELLO K, Kremer N, Richter MJ, Gall H, et al
     Inhaled Iloprost Improves Right Ventricular Load-Independent Contractility in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2022 Apr 15. doi: 10.1164/rccm.202201-0095.
     PubMed    
     
     
     
120. MINHAS J, Baird G, Appleby D, McClelland R, et al
     Terminal Digit Preference in Pulmonary Hypertension Endpoints.
     Am J Respir Crit Care Med. 2022 Apr 5. doi: 10.1164/rccm.202108-2015.
     PubMed    
     
     
     
121. VIZZA CD, Lang IM, Badagliacca R, Benza RL, et al
     Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
     Am J Respir Crit Care Med. 2022;205:751-760.
     PubMed     Abstract available
     
     
     February 2022
122. EVRARD B, Goudelin M, Vaidie J, Fedou AL, et al
     Severe Acute Cor Pulmonale in COVID-19 ARDS Patients: Caution with Left Turn.
     Am J Respir Crit Care Med. 2022 Feb 4. doi: 10.1164/rccm.202107-1568.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.